Leanna-Marie Robertson, University Hospitals Case Medical Center, USA
Dr. Leanna-Marie Robertson is a physician at University Hospitals Case Medical Center in Cleveland, Ohio. Her medical training is in the field of Internal Medicine. She has a special interest in the subspecialty of Allergy and Immunology.
Hypersensitivities Immune deficiency syndromes.
Xintao Hu, National Cancer Institute, USA
I was enrolled as Graduate Partnerships Program at NIH, USA and awarded pre-doctoral fellow by Vaccine Research Center at NIAID to conduct my Ph.D. dissertation research from 2011 to 2012. After obtaining my Ph.D. degree in immunology from Chinese Center for Disease Control and Prevention (China CDC), Beijing, China in July 2012, I continued my research work at National Cancer Institute at NIH, the USA as a postdoctoral fellow. During my Ph.D. study, my research efforts focused on dissecting the adaptive immune responses mainly humoral immune responses mounted during natural HIV-1 infection to inform valuable information for rational preventive and therapeutic strategy development against AIDS/HIV. Currently, my research efforts extended to the novel vaccine development against HIV/SIV and testing them in the non-human primate model and further identified the immune protection mechanism of candidate vaccines against SIV/HIV. Additionally, I am exploring the novel combined therapy strategies including gene therapy and immunization approaches to eradicate/remiss the latent reservoir for HIV/SIV. I serve as editor board member for the Academia Journal of Scientific Research, the BAOJ HIV, the ARC Journal of AIDS, the Journals of Scientific & Academic Publishing, the Journal of Child, Adult Vaccines and Immunology and reviewer for multiple international peer-reviewed journals. I am also the member of American Society for Microbiology (ASM) and the American Association for the Advancement of Science (AAAS).
Virology and Immunology mainly including the following directions:
1) Infection and immunity for medical viruses including HIV/AIDS.
2) Rational Development of Preventive and Therapeutic Strategy against retroviruses including SIV/HIV.
3) Dissection of Immune Protection mechanism of candidate vaccines against SIV/HIV.
4) Immunization strategy optimization and novel adjuvant discovery.
Minal Mulye, Indiana University School of Medicine, USA
Rupinder K Kanwar, North American Universities, Australia
Dr Rupinder K Kanwar completed her PhD from PGIMER, India. Since then she has worked in India, New Zealand and Australia, on various positions supporting and building new research programs related to interdisciplinary research, international collaborations and large-scale initiatives ranging from biomedicine to nanomedicine. She has a multi-award winning academic career with 16 years’ research experience in drug discovery targeting cancer and chronic inflammation, with 105 publications in high ranking journals of the field. Dr Kanwar’s industry funded research generated several patents and live applications. Her current research focuses on nanodrug and nanodiagnostic developments targeting molecular pathogenesis of chronic inflammatory diseases and cancer. At Deakin University, she is providing leadership to her research team in deciphering novel molecular targets for protein biodrugs to treat cancer and cardiomyopathy. She is a recipient of 2015 Vice Chancellor’s Award for Excellence in HDR Research Supervision (Highly Commended)& 2013 Vice Chancellor’s Award for Outstanding Contribution to Deakin Connectedness (in Service to Deakin). Her team’s presentations have won several awards at conferences. Dr Kanwar actively serves as an editorial advisory board member and reviewer of several international journals. Dr Kanwar has served on the conference organizing committees, and been invited as a speaker, and chair in national & international conferences.
Her current research focuses on nanodrug and nanodiagnostic developments targeting molecular pathogenesis of chronic inflammatory diseases and cancer.
Panagiotis Skendros, Democritus University of Thrace, Greece
Innate immunity, autoinflammatory syndromes and systemic autoimmunity.
Giuseppe Murdaca, University of Genova, Italy
Prof Giuseppe Murdaca has received his PhD in Science and Space Engineering at the University of Genova (Italy) during the period of 2000-2003. Currently, he is working as Assistant professor in Internal Medicine University of Genova (Italy). His research has included:
Immunodeficiency, Autoimmunity, Neuro-endocrino-immunology
Pharmacogenomics. Based on this research and fellowship training he has received several awards and honors, such as: Prize for young researchers of the study, assigned by the GILS, with the following motivation: "Standardization of a method to assess impairment by skinfold thickness skin", delivered on the occasion of the "Day VII Italian to fight Scleroderma" (Milan, 17/3 / 2001). Award for one of the three best oral presentations at the Ninth Congress of the Inter-SIMI Piemonte and Valle D'Aosta, Liguria (Genoa, 06.17.2004): Murdaca G., Fenoglio D., M. Setti, Brenci S., Villa R., Pontali E., A. Kunkl, Indiveri F., Puppo F. "Generation of CD4 + lines specific for Pneumocystis carinii and Candida albicans obtained from HIV + patients. Meaning of the coexpression of IFN and IL-4 ".
His research has included: Immunodeficiency, Autoimmunity,
Paola Di Carlo, University of Palermo, Italy
Emilia Dvoroznakova, Institute of Parasitology of the Slovak Academy of Sciences (SAS), Slovakia
host–parasite interactions, host defence mechanisms and immunopathological impact of parasitic infection
1• detection of the regulatory and effector mechanisms involved in the host immune response, focused on the lymphocyte phenotyping, the functional analysis of macrophages and lymphocytes, phagocytosis and respiratory burst activity, the role of cytokines in regulation of inflammatory and immune responses.
2• study of pathogenesis and changes in immunocompetent cell types and their cytokine production in parasitic zoonoses (alveolar echinococcosis, ascariasis, toxocarosis, trichinellosis) after immunomodulation and treatment.
Virmondes Rodrigues, Federal University of Triângulo Mineiro, Brazil
Immunology of Infectious disease (Leishmaniasis, Chagas' disease and Tuberculosis), with a focus on Immune response to pathogens, in special focus on identifications of Immunological and genetic factors associated with resistance or susceptibility to infection.
Lina María Yassin-Noreña, Remington University Corporation, Colombia
I am biologist and PhD in Biomedical Basic Sciences with emphasis in Immunology. I have worked as researcher mainly in cardiovascular and autoimmune diseases. However I have been also under administrative positions, coordinating a doctoral program and nowadays as vice-rector for research at Corporación Universitaria Remington, in Colombia. I am als o in charge of the “Fondo editorial Remington”, which edits academic and research books, as well as support the journal “Revista Humanismo y Sociedad” as director.
I work in immunology, mainly in cardiovascular diseases (atherosclerosis) and autoimmunity. I also have special interest for immunoregulation and cell death mechanisms.
Ricardo A. Azevedo, Federal University of São Paulo (UNIFESP), Brazil
Tumor Immunology, Phage Display, Animal models of cancer, Basic cancer research, Biochemistry, Biology and life sciences, Cancers and neoplasms, Cell adhesion, Cell death, Cell growth, Cellular stress responses, Extracellular matrix, Extracellular matrix adhesions, Immunochemistry, Integrins, Melanomas, Metastasis, Neurological tumors, Oncology, Skin tumors.
Vikrant Rai, Creighton University School of Medicine, USA
I earned my Bachelor of Medicine and Bachelor of Surgery (M.B.B.S) degree in 2007 from Dr. M.G.R. Medical University, India. I worked as a general physician in leading hospitals of New Delhi till 2011. In 2012, I came to New York and worked on the pathogenesis of cardiac remodeling and fibrosis at Albert Einstein College of Medicine, Bronx till 2014. I completed my Master’s and Ph.D. in Clinical and Translational Sciences at Creighton University School of Medicine in 2015 and 2017 respectively. My major research interest is to elucidate the targeted therapies for inflammatory and immunological diseases.
Research Interest(s): Investigating novel drug targets in inflammatory and immunological diseases
PAULO R. Z. ANTAS, University of IOC-Fiocruz, Brazil
Dr. Paulo Antas is a Professor of Biology and an Associate Researcher. He completed both MSc and PhD at FIOCRUZ, Brazil, He is also working as Editorial Board member and Reviewer for scientific journals. His wrote Book chapters and e books. In the last 5 years, he has been working in a group that develops research on the field of clinical immune response of vaccinations against human Tuberculosis (TB), especially for cellular immunology area. Most of his scientific time is currently dedicated to study several aspects of immune response in TB, such as the involvement of inflammatory cytokines, and T cells on immune response to mycobacterium as a whole. As a result, he has accumulated significant data and thus experience in this field. He spent time working in projects related to cytokine detection in patients with prior extra pulmonary TB, comparing them to those responses among persons with either pulmonary or latent infection. Therefore, accumulated data have shown defects in resting cytokine production, and have noted lower CD4 counts in HIV-seronegative patients. Primarily, these results provide evidence of defects in innate immune responses and the group published a paper raising the hypothesis of possible genetic predisposition to these immunologic defects. This work in genetics has provided him with yet another laboratory skill set that has been complementing the skills he has gained in TB immunology thus far. In addition, he has been working on innate immune response against TB in individuals naturally exposed to Mycobacterium tuberculosis at FIOCRUZ since 2007.
Amedeo Amedei, University of Florence, Italy
1. Professor Amedeo Amedei (01/04/1971) is Associate Professor at the 'University of Florence, Department of Internal Medicine ( MED / 46 ); from 2012 is the owner of "courses Applied Biology " and " Infectious Diseases " for the degree course in nursing. As for his duties he is currently in charge at the Department SOD Company Neuromuscoscheletrico University Hospital of Careggi urea test (breath test) for the detection of infection by Helicobacter Pylori . As funding for research in recent years has received from the Ministry, private and university. At present his scientific work consists of: 127 publications in international journals, citations , Impact Points of 618.77, 7 chapters of scientific books , an international patent (WO / 2007/039451), communication 43 congresses scientific, present in 'editorial board of 56 scientific journals and reviewer for 45 international journals. From November 2016 he is a member of Scientific Council of Toscana Life Science.
GUO-JIANG CHEN, Institute of Basic Medical Sciences, P.R.China
I am interested in interaction between inflammation and cancer especially in interplay between gut microbiota, mucosal immune system and gatrointestinal tumors. Specifically, I am very interested in the issues as follows (but not limited): 1. What changes happen to gut microbiota (e.g. composition and metabolites) during the growth and progression of malignancies (e.g. colorectal cancer) and the effects of this alteration on neoplastic transformation; 2. How to affect the growth and progression of gastrointestinal tumors by intestinal mucosal system (e.g. macrophage and ILCs); 3. How to foster immunosuppressive microenvironment caused by intrinsic mutation of oncogenic genes in cancer cells. And I am also interested in cancer immunology (e.g. MDSC generation and differentiation in tumor niche).
Nina Ivanovska, Institute of Microbiology,
Nina Ivanovska received her MScdegree from the Sofia University, Bulgaria in 1981. In 1987 N. Ivanovska defended her PhD at the Institute of Microbiology and Epidemiology, Medical Academy of Science, Moscow. In 2008 she received Doctor of Sciences degree. Currently N. Ivanovska is a professor at the Institute of Microbiology, Sofia, Bulgaria, where she leads the Department of Immunology. She has a great experience in the field of immunomodulation. Prof. Ivanovska has tested a lot of natural and synthetic compounds, defined their mechanisms of action and has carried out preclinical experiments in animal models of inflammation, fungal and bacterial infections, and autoimmune diseases. The main goal of her current experiments is to elucidate how inflammation impairs bone formation in concern to innate immunity cells at a molecular level and how it interferes with signalling pathways of bone formation. Another strand of her work characterises the anti-inflammatory action of tyrosine kinase inhibitors in models of sepsisand arthritis. N. Ivanovska published over 100 scientific articles, reviews and book chapters and she has beena speaker at national and international conferences on infectionsand rheumatology. Shehas supervised 7 PhD thesis worksand she has been a leader of national and international projects. Prof. N. Ivanovskais a member (past or present) in 4Editorial Boards of International Peer Review Journals (International Journal of Modern Biology and Medicine; Mediators of Inflammation; Journal of Plant Studies; International Journal of Traditional and Natural Medicine)and peer reviews for 20different journals.